Roche licenses Gryphon's synthetic erythropoiesis protein for anemia.
D000740:Anemia / Q000188:drug therapy*; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D011108:Polymers / Q000627:therapeutic use*; D011506:Proteins / Q000627:therapeutic use*; D011994:Recombinant Proteins; D013557:Switzerland
D011108:Polymers; D011506:Proteins; D011994:Recombinant Proteins; C472014:synthetic erythropoiesis protein